Referenser till artikeln "Sömnlöshet en epidemi" av Helene Sandström

1) Vgontzas AN, Bixler EO, Lin HM et al. ”Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications.” J Clin Endocrinol Metab. 2001 Aug;86(8):3787-94.
2) Palmgren G. Gener styr vår inre klocka. Illustrerad vetenskap 24-01-2011. http://illvet.se/gorm-palmgren/gener-styr-var-inre-klocka
3) Mercola J, Droege R. Want to Prevent Cancer? Make Sure You Sleep Well. http://articles.mercola.com/sites/articles/archive/2003/10/22/cancer-sleep.aspx
4) Bankhead, Charles. Sleeping Pill Death Toll May Top 500,000. 27 February 2012. MedPage Today. 2 March 2012. < http://www.medpagetoday.com/PrimaryCare/SleepDisorders/31391
5) Kripke DF. The dark side of sleeping pills. E-book: http://www.darksideofsleepingpills.com/
6) Mercola J. 'Clear Association' That Xanax, Valium, and Other Benzodiazepines Can Cause Dementia: Study. 2013-03-13. http://articles.mercola.com/sites/articles/archive/2013/03/13/benzodiazepines.aspx
7) Peart, R. Benzodiazepines, Sleeping Pills and Tranquilizers. http://www.drregpeart.org/tapering%20benzos.htm
8) Azad N, Byszewski A, Sarazin FF. Hospitalized patients' preference in the treatment of insomnia: pharmacological versus non-pharmacological. Can J Clin Pharmacol. 2003 Summer;10(2):89-92.
9) Kinosian J. The Well-Rested Woman; 60 Soothing Suggestions for Getting a Good Nights Sleep. San Francisco, Conari Press 2002.
10) Caufriez A, Leproult R , L'Hermite-Balériaux M et al. Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. J Clin Endocrinol Metab. 2011 Apr;96(4):E614-23.
11) Freyre AV, Flichman JC. Spasmophilia caused by magnesium deficit. Psychosomatics 1970;11:500–502.
12) Abbasi B, Kimiagar M, Sadeghniiat K et al. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 2012 Dec;17(12):1161-9.
13) Rondanelli M, Opizzi A, Monteferrario F et al. The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: a double-blind, placebo-controlled clinical trial. J Am Geriatr Soc. 2011 Jan.
14) Hornyak M, Voderholzer U, Hohagen F, et. al. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep 1998;21(5):501-5.
15) Ekbom KA. Restless legs syndrome. Neurology 1960;10:868–873.
16) Ulfberg J, Nystrom B. Restless legs syndrome in blood donors. Sleep Med 2004;5:115–118.
17) Demisch K, Bauer J, Georgi K, Demisch L. Treatment of severe chronic insomnia with L-tryptophan: results of a double-blind cross-over study. Pharmacopsychiatry 1987;20:242–244.
18) Hartmann E. Effects of L-tryptophan on sleepiness and on sleep. J Psychiatr Res 1983;17:107–113.
19) Hartmann E. L-Tryptophan: a possible natural hypnotic substance. JAMA 1974;230:1680–1681.
20) Henahan J. Chronic insomnia yields to serotonin precursor. Med Tribune 1984(August 15):2.
21) Adam K, Oswald I. One gram of L-tryptophan fails to alter the time taken to fall asleep. Neuropharmacology 1979;18:1025–1027.
22) Hartmann E, Lindsley JG, Spinweber C. Chronic insomnia: effects of tryptophan, flurazepam, secobarbital, and placebo. Psychopharmacology 1983;80:138–142.
23) Lindsley JG, Hartmann EL, Mitchell W. Selectivity in response to L-tryptophan among insomniac subjects: a preliminary report. Sleep 1983;6:247–256.
24) Wilhelmsson P. Näringsmedicinska uppslagsboken. Örtagårdens förlag 2006.
25) Hudson C, Hudson SP, Hecht T, et. al. Protein source tryptophan versus pharmaceutical grade tryptophan as an efficacious treatment for chronic insomnia. Nutr Neurosci 2005;8(2):121-7.
26) Gaby A. Nutritional Medicine. Fritz Perlberg Publishing 2011.
27) Gant C. The Role of 5HTP as a Precursor for Serotonin and Melatonin in the Treatment of Anxiety, Panic Disorder, Sleep Disorder, Weight Management, Fibromyalgia, Migraine and Withdrawal from Antidepressant Medication. http://www.charlesgantmd.com/articles/5HTP-as-precursor.pdf
28) Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther. 2006 Mar;109(3):325-38.
29) Schruers K, van Diest R, Nicolson N, Griez E. L-5-hydroxytryptophan induced increase in salivary cortisol in panic disorder patients and healthy volunteers. Psychopharmacology (Berl). 2002 Jun;161(4):365-9.
30) Smits MG, van Stel HF, van der Heijden K, et. al. Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomised placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2003;42(11):1286-93.
31) Valtonen M, Niskanen L, Kangas AP, et. al. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalised subjects. Nord J Psychiatry. 2005;59(3):217-21.
32) Field R. Melatonin may relieve sleep-cycle disorders. Med Tribune 1993(April 8):2.
33) Pigeon WR, Carr M, Gorman C, Perlis ML. Effects of a tart cherry juice beverage on the sleep of older adults with insomnia: a pilot study. J Med Food. 2010 Jun;13(3):579-83.
34) Howatson G, Bell PG, Tallent J et al. Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. Eur J Nutr. 2012 Dec;51(8):909-16.
35) Gomez-Ramirez M, Kelly SP, Montesi JL, Foxe JJ. The effects of L-theanine on alpha-band oscillatory brain activity during a visuo-spatial attention task. Brain Topogr. 2009 Jun;22(1):44-51
36) Weeks BS. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. Med Sci Monit. 2009 Nov;15(11):RA256-62.
37) Kakuda T. Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction. Pharmacol Res. 2011 Aug;64(2):162-8.
38) Jang HS, Jang IS et al. L-theanine partially counteracts caffeine-induced sleep disturbances in rats. Pharmacol Biochem Behav. 2012 Apr;101(2):217-21.
39) Palatnik A, Frolov K, Fux M, Benjamin J. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. J Clin Psychopharmacol. 2001 Jun;21(3):335-9.
40) Maroo N, Hazra A, Das T. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Indian J Pharmacol. 2013 Jan-Feb;45(1):34-9.
41) Fussel A, Wolf A, Brattstrom A. Effect of a fixed valerian-Hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res 2000;5:385-90.
42) Morin CM, Koetter U, Bastien C, et. al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomised placebo-controlled clinical trial. Sleep. 2005 Nov 1;28(11):1465-71.
43) Dimpfel W, Suter A. Sleep improving effects of a single dose administration of a valerian/hops fluid extract - a double blind, randomised, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms. Eur J Med Res. 2008 May 26;13(5):200-4.
44) Garges HP, Varia I, Doraiswarmy PM. Cardiac Complications and Delirium Associated with Valerian Root Withdrawal. JAMA 1998;280:1566-67.